Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder f…
Biotechnology
US, South San Francisco [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Satsuma Pharmaceuticals, Inc. (STSA) to it's peer group.
Peer Group
KRON CTMX BLCM HILS CYCN ZIVO PMVP ELYM AMTI LRMR NLTX CING PEPG TIL ERAS FBRX ASMB SNTI MNOV THRX
Compare Together
Loading...